The year 2024 has begun on a muted note in terms of FDA approvals, with only one novel drug getting endorsed in January. This is in stark contrast to the four drugs that got the regulatory nod during the same month last year.Let's take a look at the biotech companies that are awaiting FDA word on their drug candidates in February. Ipsen (IPSEY.OB)Ipsen has sought FDA approval to expand the use of ...
For comments and feedback contact: editorial@rttnews.com
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.